×

What are you searching for?




Healthcare

4 Min read

FDA requires more time to review Moderna's COVID-19 vaccine for adolescents

Published On 01 Nov 2021 10:44 AM


SHARE THIS ARTICLE  


Moderna has been told that the US FDA will require additional time to complete the assessment of its COVID-19 vaccine, for use in adolescents between the age group 12 to 17 years.

Highlights

  • FDA will require additional time for assessing Moderna’s vaccine
  • This vaccine poses a risk of Myocarditis in adolescent males

The FDA informed Moderna that the review will....


Tags : FDA, Moderna, Vaccine, Adolescents, Myocarditis,
SHARE THIS ARTICLE  

Leave a comment 

comments (0)